AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.150
-0.080 (-2.48%)
At close: Jun 12, 2025, 4:00 PM
2.970
-0.180 (-5.71%)
Pre-market: Jun 13, 2025, 7:11 AM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $940.23 million as of June 13, 2025. Its market cap has decreased by -16.95% in one year.
Market Cap
940.23M
Enterprise Value
402.81M
1-Year Change
-16.95%
Ranking
Category
Stock Price
$3.15
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $940.23M, a decrease of -94.00%. That is a compound annual growth rate of -46.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 964.11M | 11.40% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.99B |
| Johnson & Johnson | 376.94B |
| Novo Nordisk | 357.59B |
| AbbVie | 339.89B |
| UnitedHealth Group | 288.92B |
| Abbott Laboratories | 237.40B |
| Novartis AG | 236.22B |
| AstraZeneca | 232.37B |